BDBM300926 US10131658, Compound 196

SMILES: CCN(CC)c1ccc2c(-c3ccc(cc3S([O-])(=O)=O)S(=O)(=O)NCCCCCC(=O)N[C@@H](CCNC(N)=N)C(=O)Nc3ccc(C[C@H](NC(=O)C4CCCN4S(=O)(=O)c4ccccc4)C(O)=O)cc3)c3ccc(cc3oc2c1)=[N+](CC)CC

InChI Key: InChIKey=LWPORHPDJGXVMO-PXRUOCAJSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 300926   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha5beta1 (Homo sapiens (Human))	BDBM300926 (US10131658, Compound 196) Show SMILES CCN(CC)c1ccc2c(-c3ccc(cc3S([O-])(=O)=O)S(=O)(=O)NCCCCCC(=O)N[C@@H](CCNC(N)=N)C(=O)Nc3ccc(C[C@H](NC(=O)C4CCCN4S(=O)(=O)c4ccccc4)C(O)=O)cc3)c3ccc(cc3oc2c1)=[N+](CC)CC |r,wD:47.48,32.32,(22.64,-14.99,;23.41,-13.65,;22.64,-12.32,;23.41,-10.98,;22.64,-9.65,;21.1,-12.32,;20.33,-10.98,;18.79,-10.98,;18.02,-12.32,;16.48,-12.32,;15.71,-10.98,;16.48,-9.65,;15.71,-8.32,;14.17,-8.32,;13.4,-9.65,;14.17,-10.98,;13.4,-12.32,;11.86,-12.32,;12.63,-10.98,;13.4,-13.86,;13.4,-6.98,;12.63,-8.32,;14.94,-6.98,;12.63,-5.65,;11.09,-5.65,;10.32,-4.32,;8.78,-4.32,;8.01,-2.98,;6.47,-2.98,;5.7,-1.65,;6.47,-.31,;4.16,-1.65,;3.07,-.56,;3.47,.93,;4.95,1.33,;5.35,2.81,;6.84,3.21,;7.24,4.7,;7.93,2.12,;1.58,-.96,;1.18,-2.45,;.49,.13,;-1,-.27,;-1.39,-1.75,;-2.88,-2.15,;-3.97,-1.06,;-5.46,-1.46,;-6.55,-.37,;-8.03,-.77,;-9.12,.32,;-8.73,1.8,;-10.61,-.08,;-11.09,-1.55,;-12.63,-1.55,;-13.1,-.08,;-11.86,.82,;-11.86,2.36,;-10.32,2.36,;-13.4,2.36,;-11.86,3.9,;-10.52,4.67,;-10.52,6.21,;-11.86,6.98,;-13.19,6.21,;-13.19,4.67,;-6.15,1.11,;-4.66,1.51,;-7.24,2.2,;-3.57,.42,;-2.08,.82,;15.71,-13.65,;14.17,-13.65,;13.4,-14.98,;14.17,-16.32,;15.71,-16.32,;16.48,-14.99,;18.02,-14.99,;18.79,-13.65,;20.33,-13.65,;13.4,-17.65,;11.86,-17.65,;11.09,-18.99,;14.17,-18.99,;13.4,-20.32,)| Show InChI InChI=1S/C58H72N10O13S3/c1-5-66(6-2)40-24-27-44-50(35-40)81-51-36-41(67(7-3)8-4)25-28-45(51)54(44)46-29-26-43(37-52(46)84(78,79)80)82(74,75)62-31-14-10-13-19-53(69)64-47(30-32-61-58(59)60)55(70)63-39-22-20-38(21-23-39)34-48(57(72)73)65-56(71)49-18-15-33-68(49)83(76,77)42-16-11-9-12-17-42/h9,11-12,16-17,20-29,35-37,47-49,62H,5-8,10,13-15,18-19,30-34H2,1-4H3,(H8-,59,60,61,63,64,65,69,70,71,72,73,78,79,80)/t47-,48-,49?/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	505	n/a	n/a	n/a	n/a	n/a	n/a
The Regents of the University of California US Patent					Assay Description A panel of cell lines and integrin ligands were developed to allow rapid examination of potency and specificity of inhibitors against all 8 integrins...				US Patent US10131658 (2018) BindingDB Entry DOI: 10.7270/Q2SX6G8Q
					More data for this Ligand-Target Pair